Acute Coronary Syndrome
ST-Elevation Myocardial
Infarction: A Case Study
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: April 1, 2009
Expiration Date: April 1, 2010
Estimated Time of Completion: 1 hour
Description
The purpose of this activity is to examine triage to fibrinolytic therapy vs primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) for whom interhospital transfer is required but delayed, including an assessment of antithrombotic therapies in terms of selection, timing, and dosing and also the potential role of new antiplatelet agents in this setting.
Objectives
On completion of this activity, participants should be able to:
- Recognize which patients benefit from fibrinolytics vs PCI for the treatment of STEMI;
- Articulate the benefits of a system of care for STEMI and identify the factors necessary for its implementation.
Target Audience
This activity is targeted to physicians who treat patients for coronary artery disease (CAD) or see patients at some point in the course of the evaluation for potential unstable angina (UA) or myocardial infarction (MI), such as primary care physicians, emergency room physicians, or cardiologists.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
A. Michael Lincoff, MD
Professor of Medicine
Vice Chairman, Department of Cardiovascular Medicine
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Director, Coordinating Center for Clinical Research and
Vice Chairman for Clinical Research
Cleveland Clinic Lerner Research Institute
Cleveland, Ohio
Presenting Faculty
Derek P. Chew, MBBS, MPH, FRACP
Professor of Cardiology
Flinders University
Senior Research Fellow
Edwards Heart Foundation
Interventional Cardiologist
A/Director of Cardiology
Department of Cardiovascular Medicine
Flinders Medical Centre
Bedford Park, South Australia
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
A. Michael Lincoff, MD
Derek P. Chew, MBBS, MPH, FRACP
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
Daiichi Sankyo, Inc. and Eli Lilly and Company
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education,
The Cleveland Clinic Sydell and Arnold Miller Family Heart & Vascular Institute and DIME.
